Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs VGHCX overlap: 53% of top holdings shared

Bottom line

How much do FHLC and VGHCX overlap?

53% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 51.2% of FHLC's assets and 44.5% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 97), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCVGHCX
Weight overlap (top 25)53%
Shared holdings14
Weight in shared holdings51.2%44.5%
Total positions33797
Expense ratio0.084%0.33%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings FHLC and VGHCX have in common

Holding% of FHLC% of VGHCXOverlap
Eli Lilly & Co13.35%8.61%8.61%
Johnson & Johnson8.93%4.83%4.83%
AbbVie Inc6.42%2.30%2.30%
UnitedHealth Group Inc5.44%4.05%4.05%
Merck & Co Inc4.66%5.44%4.66%
CVS Health Corp1.92%2.52%1.92%
Intuitive Surgical Inc1.82%2.52%1.82%
Danaher Corp1.80%2.18%1.80%
Vertex Pharmaceuticals Inc1.76%2.36%1.76%
Elevance Health Inc1.19%1.83%1.19%
Regeneron Pharmaceuticals Inc1.15%2.14%1.15%
Boston Scientific Corp1.00%1.53%1.00%
HCA Healthcare Inc0.91%1.68%0.91%
Cencora Inc0.83%2.47%0.83%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Thermo Fisher Scientific Inc — 3.09%
  2. Amgen Inc — 3.00%
  3. Abbott Laboratories — 2.66%
  4. Gilead Sciences Inc — 2.34%
  5. Pfizer Inc — 2.06%
  6. Bristol-Myers Squibb Co — 1.93%
  7. Stryker Corp — 1.62%
  8. Medtronic PLC — 1.59%
  9. McKesson Corp — 1.52%
  10. Cigna Group/The — 1.06%
  11. Cardinal Health Inc — 0.78%

Only in VGHCX

  1. AstraZeneca PLC — 4.59%
  2. Gsk Plc — 3.00%
  3. Edwards Lifesciences Corp — 2.56%
  4. Novartis AG — 1.91%
  5. Argenx SE — 1.68%
  6. Ucb Sa — 1.67%
  7. Agilent Technologies Inc — 1.49%
  8. Biogen Inc — 1.46%
  9. Galderma Group AG — 1.37%
  10. Roche Holding AG — 1.18%
  11. Dexcom Inc — 1.18%

Asset mix

Asset typeFHLCVGHCX
Stocks99.7%97.6%
Repurchase agreements—2.2%
Cash & short-term funds0.2%0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryFHLCVGHCX
US96.5%77.6%
GB0.5%7.6%
JP—4.8%
CH0.1%4.5%
BE—3.4%
IE2.2%—
DK—1.4%
HK—0.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do FHLC and VGHCX overlap?
About 53% by weight. 14 securities appear in both funds' top 25 holdings; they make up 51.2% of FHLC's assets and 44.5% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and VGHCX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Merck & Co Inc, UnitedHealth Group Inc, AbbVie Inc.
Should I own both FHLC and VGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or VGHCX?
FHLC is broader, with 337 positions versus 97 for VGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.